Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2012 08:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year End 2011 Financial Results

CAMBRIDGE, Mass., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
January 26, 2012 13:15 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Motion for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd. Stayed

CAMBRIDGE, Mass., Jan. 26, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
December 22, 2011 16:19 ET | Source: Momenta Pharmaceuticals

Momenta to Host Investor Conference Call on December 23, 2011 to Discuss Follow-On Biologics Collaboration With Baxter

CAMBRIDGE, Mass., Dec. 22, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
December 05, 2011 08:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals

CAMBRIDGE, Mass., Dec. 5, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
December 01, 2011 14:15 ET | Source: Momenta Pharmaceuticals

TIME CHANGE: Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST

CAMBRIDGE, Mass., Dec. 1, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
November 28, 2011 17:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST

CAMBRIDGE, Mass., Nov. 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
November 07, 2011 08:51 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports $1.18 Earnings per Share for the Third Quarter of 2011

CAMBRIDGE, Mass., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
October 28, 2011 16:47 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Obtains Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.

CAMBRIDGE, Mass., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
October 24, 2011 17:13 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces That Launch of Authorized Generic Lovenox(R) Triggers Change in Collaboration Terms

CAMBRIDGE, Mass., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
October 24, 2011 10:45 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2011 Financial Results

CAMBRIDGE, Mass., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...